eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
3/2022
vol. 24
 
Share:
Send email
Share:
Original paper

Pneumococcal vaccination among adults – updated Polish recommendations

ERNEST KUCHAR
1
,
ADAM ANTCZAK
2
,
ANNA SKOCZYŃSKA
3
,
ANDRZEJ FAL
4, 5
,
JACEK WYSOCKI
6
,
Jolanta Walusiak-Skorupa
7
,
MAŁGORZATA CZAJKOWSKA-MALINOWSKA
8
,
AGNIESZKA MASTALERZ-MIGAS
9
,
ROBERT FLISIAK
10
,
ANETA NITSCH-OSUCH
11

  1. Department of Paediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland
  2. Department of General and Oncological Pulmonology, Medical University of Lodz, Lodz, Poland
  3. National Reference Centre for the Diagnostics of Bacterial Infections of the Central Nervous System (KOROUN), Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
  4. Department of Allergology, Lung Diseases and Internal Diseases, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland
  5. Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University, Warsaw, Poland
  6. Chair and Department of Health Prevention, Faculty of Health Sciences Poznan University of Medical Sciences, Poznan, Poland
  7. Department of Occupational Diseases and Environmental Health, Nofer Institute of Occupational Medicine, Lodz, Poland
  8. Department of Lung Diseases and Respiratory Failure, Centre of Sleep Medicine and Respiratory Care, Kujawy-Pomerania Pulmonology Centre, Bydgoszcz, Poland
  9. Department of Family Medicine, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland
  10. Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland
  11. Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland
Family Medicine & Primary Care Review 2022; 24(3): 285–291
DOI: https://doi.org/10.5114/fmpcr.2022.119420
Online publish date: 2022/10/03
Article file
- 16 FM&PCR 3 22 - V - Kuchar - Pneumococcal vaccination.pdf  [0.49 MB]
Get citation
 
PlumX metrics:
 
1. Tvedskov ESF, Hovmand N, Benfield T, et al. Pneumococcal carriage among children in low and lower-middle-income countries: a systematic review. Int J Infect Dis 2022; 115: 1–7, doi: 10.1016/j.ijid.2021.11.021.
2. Moghnieh R, Tamim H, Awad L, et al. Epidemiology of invasive and non-invasive pneumococcal infections in hospitalised adult patients in a Lebanese medical centre, 2006–2015. J Infect Public Health 2020; 13: 2092–2100, doi: 10.1016/j.jiph.2019.03.003.
3. Randle E, Ninis N, Inwald D. Invasive pneumococcal disease. Arch Dis Child – Educ Pract 2011; 96: 183–190, doi: 10.1136/adc.2010.191718.
4. Komunikat Głównego Inspektora Sanitarnego z dnia 28 października 2021 r. w sprawie Programu Szczepień Ochronnych na rok 2022. 2021. Available from URL: https://www.gov.pl/attachment/d051a2fe-d74b-478c-b155-05f3671ea1d5 (in Polish).
5. Factsheet about pneumococcal disease n.d. [cited 19.06.2022]. Available from URL: https://www.ecdc.europa.eu/en/pneumococcal-disease/facts.
6. Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia 2020; 12: 11, doi: 10.1186/s41479-020-00074-3.
7. Jaśkowiak K, Golicki D. Pneumokokowe zapalenie płuc u osób dorosłych – sytuacja w Polsce. 2021. Available from URL: https://prowly-uploads.s3.eu-west-1.amazonaws.com/uploads/landing_page_image/image/341692/5858ff54f8351b4cf0920a0d554614fd.pdf (in Polish).
8. Said MA, Johnson HL, Nonyane BAS, et al. Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques. PLoS ONE 2013; 8: e60273, doi: 10.1371/journal.pone.0060273.
9. Shea KM, Edelsberg J, Weycker D, et al. Rates of Pneumococcal Disease in Adults with Chronic Medical Conditions. Open Forum Infect Dis 2014; 1, doi: 10.1093/ofid/ofu024.
10. Shao Y, Stoecker C. Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review. Expert Rev Vaccines 2020; 19: 1141–1151, doi: 10.1080/14760584.2020.1874929.
11. Frank O, De Oliveira Bernardo C, González-Chica DA, et al. Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. Hum Vaccin Immunother 2020; 16: 965–971, doi: 10.1080/21645515.2019.1682844.
12. Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices – United States, 2022. MMWR Morb Mortal Wkly Rep 2022; 71: 109–117, doi: 10.15585/mmwr.mm7104a1.
13. Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial co-infection: a systematic review and meta‐analysis. Influenza Other Respi Viruses 2016; 10: 394–403, doi: 10.1111/irv.12398.
14. Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with
15. COVID-19: a retrospective cohort study. Clin Microbiol Infect 2021; 27(1): 83–88, doi: 10.1016/j.cmi.2020.07.041.
16. Bergh C, Fall K, Udumyan R, et al. Severe infections and subsequent delayed cardiovascular disease. Eur J Prev Cardiol 2017; 24: 1958–1966, doi: 10.1177/2047487317724009.
17. Averin A, Shaff M, Weycker D, et al. Mortality and readmission in the year following hospitalization for pneumonia among US adults. Respir Med 2021; 185: 106476, doi: 10.1016/j.rmed.2021.106476.
18. Chen H, Matsumoto H, Horita N, et al. Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis. Sci Rep 2021; 11: 11865, doi: 10.1038/s41598-021-91234-y.
19. Skoczyńska A, Gołębiewska A, Wróbel-Pawelczyk I, et al. Inwazyjna choroba pneumokokowa w Polsce w 2021 roku (dane KOROUN). 2022. Available from URL: http://koroun.nil.gov.pl/wp-content/uploads/2022/06/Inwazyjna-choroba-pneumokokowa-w-Polsce-w-2021-roku-dane-uzupe%C5%82nione.pdf (in Polish).
20. Streptococcus pneumoniae: Information for Clinicians | CDC n.d. [cited 15.06.2022]. Available from URL: https://www.cdc.gov/pneumococcal/clinicians/streptococcus-pneumoniae.html.
21. Moore MR, Link-Gelles R, Schaffner W, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis 2015; 15: 301–309, doi: 10.1016/S1473-3099(14)71081-3.
22. Hausdorff WP, Hanage WP. Interim results of an ecological experiment – conjugate vaccination against the pneumococcus and serotype replacement. Hum Vaccin Immunother 2016; 12: 358–374, doi: 10.1080/21645515.2015.1118593.
23. Andrews N, Kent A, Amin-Chowdhury Z, et al. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: the indirect cohort design, 2006–2018. Vaccine 2019; 37: 4491–4498, doi: 10.1016/j.vaccine.2019.06.071.
24. Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines. Nat Rev Immunol 2009; 9: 213–220, doi: 10.1038/nri2494.
25. CHMP Variation Assessment Report – Prevenar 13 2011 [cited 09.09.2022]. Available from URL: https://www.ema.europa.eu/en/documents/variation-report/prevenar-13-h-c-1104-ii-0028-epar-assessment-report-variation_en.pdf.
26. Pletz MW, Maus U, Krug N, et al. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 2008; 32: 199–206, doi: 10.1016/j.ijantimicag.2008.01.021.
27. Bröker M, Berti F, Schneider J, et al. Polysaccharide conjugate vaccine protein carriers as a “neglected valency” – potential and limitations. Vaccine 2017; 35: 3286–3294, doi: 10.1016/j.vaccine.2017.04.078.
28. Dziennik Urzędowy Ministra Zdrowia ogłoszony: 20.12.2021 [cited 4.06.2022]. Available from URL: http://dziennikmz.mz.gov.pl/legalact/2021/100/ (in Polish).
29. National Center for Immunization and Respiratory Diseases. General recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011; 60: 1–64.
30. Mikulska M, Cesaro S, Lavallade H de, et al. Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 2019; 19: e188–e199, doi: 10.1016/S1473-3099(18)30601-7.
31. Cordonnier C, Einarsdottir S, Cesaro S, et al. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 2019; 19: e200–e212, doi: 10.1016/S1473-3099(18)30600-5.
32. Baden LR, Swaminathan S, Angarone M, et al. Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 2016; 14: 882–913, doi: 10.6004/jnccn.2016.0093.
33. Parczewski M, Bociąga-Jasik M, Inglot M, et al. Zasady opieki nad osobami zakażonymi HIV. Zalecenia Polskiego Towarzystwa Naukowego AIDS. Warszawa: Polskie Towarzystwo Naukowe AIDS; 2019 (in Polish).
34. Araszkiewicz A, Bandurska-Stankiewicz E, Borys S, et al. 2021 Guidelines on the management of patients with diabetes. A position of Diabetes Poland. Clin Diabetol 2021; 10: 1–113, doi: 10.5603/DK.2021.0001.
35. Gupta N, Malhotra N, Ish P. GOLD 2021 guidelines for COPD – what’s new and why. Adv Respir Med 2021; 89: 344–346, doi: 10.5603/ARM.a2021.0015.
36. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42: 3599–3726, doi: 10.1093/eurheartj/ehab368.
37. Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016; 37: 67–119, doi: 10.1093/eurheartj/ehv317.
38. Furer V, Rondaan C, Heijstek MW, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2020; 79: 39–52, doi: 10.1136/annrheumdis-2019-215882.
39. Danziger‐Isakov L, Kumar D. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant 2019; 33, doi: 10.1111/ctr.13563.
40. Yang X, Zhang D, Ou W. Pneumococcal vaccination patterns among persons aged 65 years or older in the United States: a retrospective database analysis. Vaccine 2018; 36: 7574–7579, doi: 10.1016/j.vaccine.2018.10.015.
41. Ibrahim L, Manjani L, Nassar A, et al. A Double Whammy: A Case Report and Review of the Literature on Pneumococcal Coinfection in COVID-19 Patients. Cureus 2021, doi: 10.7759/cureus.13322.
Copyright: © 2022 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.